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A B S T R A C T
Leigh syndrome (LS) associated with cytochrome c oxidase (COX) deﬁciency is an early onset, fatal mitochon-
drial encephalopathy, leading to multiple neurological failure and eventually death, usually in the ﬁrst decade of
life. Mutations in SURF1, a nuclear gene encoding a mitochondrial protein involved in COX assembly, are among
the most common causes of LS. LSSURF1 patients display severe, isolated COX deﬁciency in all tissues, including
cultured ﬁbroblasts and skeletal muscle. Recombinant, constitutive SURF1−/− mice show diﬀuse COX deﬁ-
ciency, but fail to recapitulate the severity of the human clinical phenotype. Pigs are an attractive alternative
model for human diseases, because of their size, as well as metabolic, physiological and genetic similarity to
humans. Here, we determined the complete sequence of the swine SURF1 gene, disrupted it in pig primary
ﬁbroblast cell lines using both TALENs and CRISPR/Cas9 genome editing systems, before ﬁnally generating
SURF1−/− and SURF1−/+ pigs by Somatic Cell Nuclear Transfer (SCNT). SURF1−/− pigs were characterized by
failure to thrive, muscle weakness and highly reduced life span with elevated perinatal mortality, compared to
heterozygous SURF1−/+ and wild type littermates. Surprisingly, no obvious COX deﬁciency was detected in
SURF1−/− tissues, although histochemical analysis revealed the presence of COX deﬁciency in jejunum villi and
total mRNA sequencing (RNAseq) showed that several COX subunit-encoding genes were signiﬁcantly down-
regulated in SURF1−/− skeletal muscles. In addition, neuropathological ﬁndings, indicated a delay in central
nervous system development of newborn SURF1−/− piglets. Our results suggest a broader role of sSURF1 in
mitochondrial bioenergetics.
1. Introduction
Leigh syndrome (LS, OMIM 256000) associated with cytochrome c
oxidase (COX) deﬁciency is an early onset, genetically heterogeneous
disease characterized by subacute neurodegenerative encephalopathy
[1,2]. The typical course of LS includes neurodevelopmental regression,
brain stem and basal ganglia signs (ataxia, dystonia, chorea, optic
atrophy, ophthalmoparesis, swallowing and/or feeding diﬃculties,
tongue fasciculations, and apnoeic episodes) and characteristic mag-
netic resonance imaging (MRI) ﬁndings, including symmetrical lesions
in the basal ganglia, thalamus, cerebellum, and brain stem. Other
manifestations may include failure to thrive, microcephaly,
hypertrichosis, and myopathy [1,3,4]. Lactic acid levels in the blood
and cerebrospinal ﬂuid of the patients are often elevated, and COX
activity is< 20% compared to normal ﬁbroblasts, lymphocytes, or
muscle biopsies. COX is the terminal component of the mitochondrial
respiratory chain and catalyzes the electron transfer from reduced cy-
tochrome c to oxygen whilst pumping protons from the mitochondrial
matrix to the intermembrane space, across the inner mitochondrial
membrane.
Mutations in SURF1 account for about one third of LS cases and are
by far the most frequent cause of LS associated with isolated COX de-
ﬁciency [5,6]. Although SURF1-related LS is a well-established neuro-
pathological and clinical entity, atypical manifestations have been
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occasionally reported, such as long-surviving cases with scarce brain
lesions [3,7], or subjects manifesting predominant demyelinating
Charcot-Marie-Tooth disease [8], villous atrophy, hypertrichosis
without the typical brain lesions [9], or severe renal involvement [10].
Some cases of leukodystrophy with systemic COX deﬁciency were also
reported [3,11,12]. However, severe isolated COX deﬁciency and ne-
crotizing encephalomyelopathy remain the most common biochemical
and clinical-pathological hallmarks of the disease.
In humans, the SURF1 gene is located on chromosome 9q34 in a
cluster of genes with a peculiar genomic structure conserved
throughout the vertebrate radiation, called the surfeit locus. Orthologues
of SURF1 are present in virtually all eukaryotes, from yeast to mam-
mals. Human SURF1 (hSURF1) is a 300-amino acid protein located in
the inner mitochondrial membrane, deemed to be involved in the as-
sembly and maintenance of COX, although its exact function is still not
fully understood. Truncating mutations in the N-terminal, central, or C-
terminal regions of hSURF1 result in an unstable protein unable to
rescue COX activity in SURF1-deﬁcient cell lines [13]. In the last
decade, several attempts to generate SURF1-deﬁcient LS animal models
have been made, with controversial results. For instance, constitutive
recombinant SURF1−/− mice showed mild but signiﬁcant COX deﬁ-
ciency and slight elevation of blood lactate, but failed to recapitulate
the main human clinical signs, and yet they displayed a surprising in-
crease in longevity and enhanced memory [14,15]. A SURF1 knock-
down zebraﬁsh model showed COX deﬁciency with cardiac and en-
dodermal developmental defects, abnormal swimming behaviour, and
increased apoptosis in the hindbrain and neural tube [16]. In a LS
Drosophila model, the constitutive SURF1 knockdown is lethal in larvae
that however display defects in all complexes of the mitochondrial re-
spiratory chain (MRC) and impaired muscular development. In a con-
ditional central nervous system (CNS)-restricted Drosophila model the
knockdown of SURF1 leads to isolated COX deﬁciency in adult ﬂies
[17]. The failure of small animal models, in particular rodents, to mimic
the main features of the human syndrome prompted us to generate a
large animal model [18]. Over the last 20 years, swine (Sus scrofa) has
been increasingly used as a suitable animal model in various biomedical
research programs [19–21]. Pigs share a number of anatomic and
physiologic features with humans that make them a promising animal
model for investigating a range of human diseases. New genome-editing
technologies, based on TAL eﬀector-like nucleases (TALENs) and clus-
tered regularly interspaced short palindromic repeats (CRISPRs)/Cas9
site-speciﬁc nucleases (SSNs), recently boosted the use in research of
species other than mouse. Here we exploited these technologies to
generate a SURF1−/− pig, the ﬁrst swine model of a mitochondrial
disease.
2. Materials and methods
2.1. Animal experiments
All procedures involving the use of animals in this study were ap-
proved by the Local Ethics Committee of Avantea, carried out in ac-
cordance with the Italian Law (D.Lgs 26/2014) and EU directive 2010/
63/EU regulating animal experimentation and approved by relevant
authorities (Ministry of Health project n 606/2016-PR).
2.2. Chemicals
All chemicals and reagents were purchased from Sigma (Milan,
Italy), unless otherwise stated.
2.3. Ampliﬁcation and sequencing of the swine genomic SURF1 gene
The whole sSURF1 gene was PCR-ampliﬁed using S1F-long and S1R-
long primers using genomic DNA of cell line ID6639 (commercial pig
hybrid, Large White x Landrace) as a template. The sequences of all the
primers used in this study are reported in Supplementary Table S3.
Ampliﬁcation was performed in 12.5 μL reaction volume (0.4 mM
dNTPs, 0.8 μM each primer, 0.05 U/μl LA-Taq in GCI Buﬀer, Nuclease-
free H2O to volume) using a touchdown protocol (Supplementary
methods).
The PCR product (4582 bp, Supplementary Fig. 1A) was cloned into
TOPO-TA vector (Invitrogen, Thermo Scientiﬁc, Waltham, MA USA),
transformed into competent DH5α strain of E. coli and Sanger-se-
quenced (GATC Biotech, Constance, Germany). sSURF1 cDNA was
cloned from the cell line ID6639 by reverse transcription of puriﬁed
mRNA, followed by PCR ampliﬁcation using gene speciﬁc primers S1F
and S1R (Supplementary Table S3). RNA extraction was performed
using a guanidine thiocyanate protocol [22]. Reverse transcription was
performed using RevertAid H Minus First Strand cDNA Synthesis Kit
(Thermo Scientiﬁc, Waltham, MA USA). The speciﬁc PCR product is
921 bp. This cDNA sequence was used to conﬁrm the sequences of
exons 1 to 9.
2.4. Cell isolation and culture
Primary porcine ﬁbroblast cultures were derived from adult Large
White× Landrace hybrid female (ID167, Avantea) and male (ID6639)
ear biopsies (pig adult ﬁbroblasts, PAFs) and 40-day-old male foetus
biopsy (Pig Foetal Fibroblasts after CRISPR editing, PFFs; IDclone-5,
cloned from ID6639), by cutting the biopsies in small pieces with a
scalpel blade. Tissue pieces were plated in triplicate in 60-mm culture
dishes with 2mL of DMEM/TCM199 (1:1) supplemented with 20%
Foetal Bovine Serum (FBS). Cells were allowed to grow until 50% of
conﬂuence with medium changes every 3 days, then tissue fragments
were removed and cells sub-cultured in 4mL of DMEM/TCM199 (1:1)
supplemented with 10% FBS and bFGF (5 ng/mL) until 80% of con-
ﬂuence. Cells were then cryopreserved at early passages in DMEM/
TCM199 (1:1) with 20% FBS and 10% DMSO and stored in liquid ni-
trogen. These batches were used throughout the experiments. The same
procedure was followed for the setting up of SURF1 animals cell lines
bio-bank.
2.5. CRISPR/Cas9 and TAL eﬀector nucleases (TALENs) design and
validation
CRISPR/Cas9 system sgRNA guides were designed to target swine
SURF1 exon 3 according to the software CRISPR Design Tool (www.
crsipr.mit.edu). Two high quality guides, with predicted high eﬃciency
(score > 50) were chosen (Supplementary Table S2). Complementary
oligonucleotides for each guide were annealed to generate duplex and
cloned in the CAG-hspCas9-H1-gRNA linearized Smart Nuclease vector
according with the user manual (CAS920A-1 System Biosciences).
TALEN vectors design and production was outsourced to Genecopoeia
(www.genecopoeia.com) to target exon 3 and exon 4 of the swine SURF1
gene (GenBank: AK391958.1). Three diﬀerent TALENs pairs were pur-
chased (Supplementary Table S1). For each TALEN pair, pig ﬁbroblast
(1 ∗ 106 cells, ID6639) were transfected (Nucleofector TM, LONZA, Basel,
Switzerland) and each pool obtained was plated in 60-mm culture dish
and harvested 72 h post transfection for lysis and genomic DNA extraction.
Both CRISPR/Cas9 and TALENs eﬃciency was evaluated through
Surveyor® Assay (IDT Surveyor® Mutation Detection Kit, Iowa, USA).
2.6. Transfection of pig ﬁbroblasts and screening
Initial transfection with CRISPR/Cas9 were performed without the tar-
geting vector and puromycin selection generated only SURF1+/− cells,
therefore a two-step strategy was implemented to obtain SURF1−/− ﬁbro-
blasts (Supplementary Fig. 3). As a consequence for the TALENs editing
strategy, aiming at the one step generation of SURF1−/− ﬁbroblasts the
targeting vector was always used to generate both males and females edited
cells.
C. Quadalti et al. BBA - Molecular Basis of Disease 1864 (2018) 2131–2142
2132
PAFs were thawed two days before transfection in order to have
1 ∗ 106 cells/transfection.
For CRISPRs transfection experiments, cells were prepared as above
and Nucleofector TM solution was supplemented with 3 μg of the CAG-
hspCas9-H1-gRNA vector with or w/o the addition of 2 μg of the HR
vector (1:1) for co-transfection experiments. The cell suspension was
transferred in the transfection cuvette and program V-024 was used for
all transfections, as previously described [23]. For colony isolation,
transfected cells were plated single-cell in 150-mm culture dishes with
fresh culture medium. Where HR vector was used, after 24 hours pur-
omycin (1 μg/mL) was added for selection. After 8 days of antibiotic
selection, puromycin-resistant colonies were picked and transferred
into 24-well dishes with fresh culture medium. For each colony, an
aliquot was cryopreserved in liquid nitrogen (DMEM/TCM199 1:1, 20%
FBS and 10% DMSO) for subsequent SCNT (Somatic Cell Nuclear
Transfer) and the remaining cells lysed for genomic extraction, PCR-
analysed and Sanger-sequenced for both the integration of the targeting
vector and the presence of InDels. Genomic DNA was extracted (see
Supplementary methods), ampliﬁed with the primers Ex2Fw – Ex4Rv
(see Supplementary Table S3) and sequenced. Conﬁrmed NHEJ-mu-
tated SURF1+/− colonies were used for ﬁrst step-SCNT and foetuses
(D+40 of gestation) were collected to establish PFF cell lines. The
rejuvenated PFF genotype was conﬁrmed and cells were used for a
second round of co-transfection (HR vector+ CAG-hspCas9-H1-gRNA
1:1) to obtain SURF1−/− colonies. Puromycin resistant colonies were
screened by PCR using Ex2Fw and PuroF2-R oligos (Supplementary
Table S3). First-step SURF1+/− NHEJ-mutated colonies were also used
as nuclear donor cells for the generation of SURF1+/− piglets.
For TALENs transfections, cells were trypsinized, counted and re-
suspended in Nucleofector TM solution (Basic Nucleofector TM Kit,
Primary Fibroblasts, LONZA, Basel, Switzerland) supplemented with
2 μg of each TALEN arm (L+R) plasmid and 1 μg of HR vector (not
used in transient transfection) (Supplementary methods). Recombinant
colonies were screened by PCR for NHEJ-derived mutations using the
S1TF and S1TR oligos giving a 375 bp product (Supplementary Table
S3); for the integration of the HR vector the Ex2F+PuroF2-R oligos,
amplifying a 1237 bp fragment, were used (Supplementary Table S3).
NHEJ was conﬁrmed by Sanger sequencing (Supplementary methods).
2.7. Somatic Cell Nuclear Transfer (SCNT)
The protocol used was the one described in [24] with minor mod-
iﬁcations. Brieﬂy, ovaries of pubertal gilts were collected at a local
abattoir and transported to the laboratory at 31 °C–33 °C. Follicles
larger than 3mm were aspirated and cumulus-oocyte complexes were
selected and in vitro matured in deﬁned maturation medium at 38.5 °C
in 5% CO2 in humidiﬁed air for 42 h. The day before SCNT, selected
nuclear donor cells were induced into quiescence by serum starvation
(0.5% FCS). The day of SCNT, cells were trypsinized, washed and re-
suspended in SOF [25] supplemented with 25mM Hepes (SOF-Hepes).
At the end of maturation process, only matured oocytes were selected
(presence of an extruded polar body). NT-embryos were reconstructed
following a zona-free method [26], where the zona pellucida was di-
gested with 0.5% pronase in PBS. All manipulations were performed in
SOF-Hepes with 10% FCS. Enucleation was performed following a
5minutes exposure to cytochalasin B (7.5 μg/mL) and Hoechst (5 μg/
mL). Enucleated cytoplasts were then rinsed in phytohemagglutinin P
in PBS and quickly dropped over a single nuclear donor cell prepared
after trypsinization. Donor cell-cytoplast couples were washed in 0.3 M
mannitol solution and fused by double DC-pulse (1.2 KVolt/cm) and
returned in to maturation medium. After 2 h, at about 48 h of ma-
turation, NT embryos were activated by double DC-pulses [24], fol-
lowed by 2 h in maturation medium supplemented with cytochalasin B
(5 μg/mL) and cycloheximide (10 μg/mL) to avoid polar body extru-
sion. At the end of the activation, reconstructed embryos were cultured
in mSOF supplemented with essential and non-essential amino acids
and with 4mg/mL BSA, in a modiﬁcation of the Well Of the Well
system [27] and the culture was continued as described in [24].
2.8. Recipient sows synchronization, surgical Embryo Transfer (ET) and
post-implantation development
Recipient sows oestrus was synchronized by feeding 12mg of al-
trenogest (Regumate, Intervet, Peschiera Borromeo, Italy) per sow for
15 days, followed by an injection of 0.15mg of PgF2α (Dalmazin, Fatro,
Ozzano Emilia, Italy) at the 13th day of altrenogest treatment and one
of 1000 IU of hCG (Chorulon, Intervet, Peschiera Borromeo, Italy) 96 h
after the last altrenogest treatment. SCNT embryos were surgically
transferred to the uterus of synchronized sows on day 6 of development
(compacted morula and early blastocyst stages) through a mid-ventral
laparotomy procedure [28], ﬁve days after standing oestrus. Recipients
were checked for pregnancy by trans-abdominal ultrasound examina-
tion 30 days after ET and pregnancy were conﬁrmed around day 60
post-ET. Farrowing was induced by a PgF2α injection on day 119 and
120 of gestation. After birth, all animals were genotyped (Supplemen-
tary methods).
2.9. Isolation of mitochondria
Standard methods were used for the preparation of mitochondrial
and post-mitochondrial fractions from pig tissues (brain, muscle and
liver) [29] (Supplementary methods).
2.10. Biochemical and clinical analysis
Spectrophotometric assays of individual respiratory complex activ-
ities were carried out on tissue homogenates and on cultured cell ly-
sates as described [30]. Speciﬁc activities of each complex were nor-
malized to that of citrate synthase (CS), an index of mitochondrial mass.
Blood lactate was measured using the Lactate Assay Kit and protocol
(Sigma, St Louis, MO, USA). For newborns, the Lactate Scout Analyzer
[31] (EKF Diagnostics, Cardiﬀ) was used in order to minimize the
amount of blood, and thus stress. Measurements started a few hours
after birth and continued periodically along the piglets' life. As piglets
were allowed to feed under the recipient mother sow and diﬀerences in
birth weight can inﬂuence their capacity to feed properly in competi-
tion with littermates [32], we divided animals in weight groups and
compared, for each group, SURF1−/− and SURF1+/− animals, and age-
and weight-matched controls. We also measured blood lactate levels in
one longer-lived SURF1−/− animal (ID498 at 58 days of age) compared
with two age-matched controls. In order to avoid side eﬀects related to
pad puncture of heavier animals, we chose to take a 200 μL blood
sample from ear vein and measure blood lactate following the in-
structions of the Lactate reagent kit (Sigma); we followed this proce-
dure for both ID498 and relative controls.
Standard blood test analyses were performed on SURF1−/−,
SURF1+/− and age-matched control animals. In addition to standard
blood analysis, TSH, FT3 and FT4 levels were also analysed using
standard diagnostic methods.
Western blot, Blue Native and In-Gel activity analysis are described
in Supplementary methods.
2.11. Histochemical and histological analysis of pig tissues
For histochemical studies of quadriceps and jejunum samples, tis-
sues were frozen in liquid-nitrogen precooled isopentane and serial 8-
μm-thick sections were stained for COX, SDH and NADH as previously
described [33].
Brains were ﬁxed by immersion in 10% buﬀered formalin, em-
bedded in paraﬃn and 5 μm sectioned. For histological analyses, sec-
tions were stained with hematoxylin–eosin or Luxol Fast Blue/
Hematoxylin and visualized under a light microscope (Leica
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Microsystem). For immunohistochemistry, sections were quenched for
30min in methanol and 0,3% hydrogen peroxide. Antigen retrieval was
performed by incubating the slides in 10mM citrate buﬀer (pH 6.0) for
15min. For immunoﬂuorescence analyses, brains were ﬁxed in 4% PFA,
cryoprotected in 30% sucrose and embedded in O.C.T. compound
frozen in liquid-nitrogen-cooled isopentane. Twenty μm thick sections
were cut with cryostat, permeabilized in 0,5% triton X- 100 in PBS for
20min and blocked in 5% normal donkey serum in PBS for 1 h. The
following primary antibodies were incubated overnight at 4 °C: anti-
GFAP (1: 1000; Millipore), anti Iba 1 (1: 600, Biocare), anti-Cleaved
Caspase 3A (1: 300, Cell Signaling), anti MBP (1: 400, Millipore), anti
DCX (1:1000, abcam).
After several washes, slides were incubated with the biotinylated
secondary antibody followed by ABC complex reagents (Vector Labs)
and DAB staining. For immunoﬂuorescence, the following secondary
antibodies were used: donkey Alexa Fluor 488 or 555 conjugated
(Thermo Fisher Scientiﬁc). Slides were then washed in PBS, counter-
stained with DAPI and mounted with Fluoromount G
(SouthernBiotech). All ﬂuorescence images were captured on a confocal
laser- scanning microscope (Leica TCS SP8, Leica Microsystem). To
label endothelial cells biotinylated Griﬀonia Simplicifolia Lectin I
(Isolectin B4 1: 400, Vector Labs) was used.
2.12. Quantiﬁcation of brain sections
The thickness of the cerebral cortex grey matter was quantiﬁed
using the software NIS Elements (Nikon). Object identiﬁcation was
performed using a protocol adapted from Lin et al., 2005 and Chen
et al., 2007 [34,35]. A constant sized image segment was converted to 8
bits per pixel grey scale. The images were then binarized using a ﬁxed
interval intensity threshold series, followed by erosion/dilation ﬁltering
to detect boundaries of object. Fluorescent signal areas were binarized,
quantiﬁed and expressed as a percentage of the total area. Image ana-
lyses were performed using ImageJ.
2.13. Mitochondrial morphology evaluation
Mitochondrial morphology was assessed after vital cell staining with
10 nM Mitotracker CMX-Red (Invitrogen) for 30min at 37 °C.
Fluorescence was visualized with a digital imaging system using an
inverted epiﬂuorescence microscope with a 63/1.4 oil objective (Nikon,
Japan). Images were captured with a back-illuminated Photometrics
Cascade CCD camera system (Crisel).
2.14. - Total mRNA sequencing experiment and data analysis
Diﬀerential expression of genes between the SURF1 knock-out and
wild type samples was evaluated by DESeq2 [25516281] by IGA
Technology Services, Udine, Italy. Quadriceps samples from 2 live
SURF1−/− male animals on day 1 after birth and from 2 matching
controls were collected immediately after euthanization and conserved
at −80 °C in RNAlater. TruSeq Stranded mRNA Sample Prep kit
(Illumina, San Diego, CA) has been used for library preparation fol-
lowing the manufacturer's instructions, starting with 1–2 μg of good
quality RNA (R.I.N.> 7) as input. The poly-A mRNA was melted 3min
at 94 °C and every puriﬁcation step has been performed by using 1×
Agencourt AMPure XP beads. Both RNA samples and ﬁnal libraries
were quantiﬁed by using the Qubit 2.0 Fluorometer (Invitrogen,
Carlsbad, CA) and quality tested by Agilent 2100 Bioanalyzer RNA
Nano assay (Agilent technologies, Santa Clara, CA). Libraries were then
processed with Illumina cBot for cluster generation on the ﬂowcell,
following the manufacturer's instructions and sequenced on paired-end
125 bp mode on HiSeq2500 (Illumina, San Diego, CA) with a median
73.8M of reads/sample (min 52.8M, max 86.3M). The CASAVA 1.8.2
version of the Illumina pipeline was used to process raw data for both
format conversion and de-multiplexing.
Statistically signiﬁcant enrichment of GO terms in genes that were
under- or over-expressed was evaluated by using DAVID [PMID:
22543366].
2.15. Statistical analysis
Two-tailed, unpaired, unequal variance Student's t-test and ANOVA
with post-hoc Tukey HSD test were used for statistical analysis. Survival
probability was calculated using the Kaplan–Meier and log-rank tests
(XLSTAT, Addinsoft). The data are shown as mean ± SEM.
For RNAseq analysis, we determined whether the biases in the ex-
pression levels were statistically signiﬁcant.
3. Results
3.1. Molecular characterization of the swine SURF1 gene
Only three exons (exons 2–4) of swine SURF1 gene were annotated
on public databases (NC_010449.4). We used this information and the
human SURF1 (hSURF1) sequence to PCR-amplify the full-length swine
sSURF1 genomic locus from the wild type cell line ID6639. A single PCR
product of 4582 bp was obtained (Supplementary Fig. 1A) and fully
sequenced (NCBI: BankIt2034014 Surf1 MF535518). By using the swine
mRNA (NCBI AK391958) and the hSURF1 genomic (NG_008477.1) se-
quences, we were able to place all 9 exons (Fig. 1A). The sequences of
the exons were further validated by directly sequencing the sSURF1
cDNA extracted from pig ﬁbroblasts. The human and swine proteins
showed 80% identity and 87% similarity by Clustal OMEGA alignment
(Supplementary Fig. 1B). Further genomic analysis located the sSURF1
gene on chromosome 1 (ENSSSCG00000035727).
3.2. Disruption of SURF1 gene in swine primary ﬁbroblasts
For the CRISPR/Cas9 experiment, we initially used a speciﬁc guide
RNA (gRNA) to disrupt the sSURF1 gene by non-homologous end
joining (NHEJ) in the male cell line. We obtained 16/118 colonies with
site-speciﬁc InDels, in particular all were characterized by a single base
pair insertion (+A) (Table 1 and Supplementary Fig. 2B) and one of
these (F4) was used for SCNT to obtain rejuvenated porcine foetal ﬁ-
broblasts (PFFs, clone-5). These were then used to perform a second
round of CRISPR/Cas9 transfection using the same gRNA in combina-
tion with the HR vector, which harbours a 106 bp deletion (Δ106) on
the left homology arm of exon 3 as well as a puromycin-resistance
(Puro-R) cassette, in order to obtain sSURF1−/− colonies. We obtained
14/100 clones positive for the homologous insertion of the HR targeting
vector. These were veriﬁed by PCR and Sanger sequencing, and four
(171C2, 171C5, 171D4, 171F3) were used as nuclear donor cells in
SCNT experiments. This two-step procedure is summarized in Supple-
mentary Fig. 3. The functional outcome of this editing is the disruption
of exon 3 on one allele by HR and of the other allele by the NHEJ-driven
insertion of an A. The latter results in a frameshift mutation with a
predicted mRNA product that will code for a protein of 64 aa against
the original mRNA of 306 aa (see Fig. S1).
In the experiment with TALENs we obtained 32/48 and 23/42 targeted
colonies with Tal01 and Tal02 respectively on the male cell line (Table 1).
In both cases, the targeted clones carried the Puro-R targeting vector in one
allele as a consequence of HR. We then veriﬁed the presence of additional
mutations attributable to NHEJ in the second allele. Previous experiments
showed that colonies carrying large (>20bp) InDels were not suitable for
SCNT and they were therefore discarded. Therefore 4 cell clones sSURF1−/
− carrying ≤5 bp, out-of-frame mutations were used for the ﬁrst SCNT
experiment: Tal01A6: ins. 4 bp (CAGC), Tal01C2: del. 5 bp (AGGCC),
Tal01C7: del. 5 bp (AGCAG), Tal02B5: del. 2 bp (TC). We obtained 5 ani-
mals (see Fig. 2 ﬁrst row) and then the apparently ﬁttest animal, ID 487,
obtained by Tal01C2: del. 5 bp (AGGCC), was used to re-clone by nuclear
transfer all the animals of the study including those that were used for
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RNASeq (Supplementary Fig. 2). As in the case of CRISPR, also with TALENs
these editing procedures resulted in the disruption by the insertion of Puro-
R in exon 3 of one allele and in the NHEJ-driven 5 bp deletion in exon 3 of
the other allele. The latter results in a frameshift mutation with a predicted
mRNA product encoding a truncated protein of 53 aa against the wild-type
one of 306 aa (see Fig. S1). The female cells were selected as described for
the male cell line; 25/38 clones carried heterozygous mutations corre-
sponding to the HR allele targeted with Puro-R and a WT allele. A pool of 6
of these clones (A2Tal01, A3Tal01, A6Tal01, B4TaL01, B5Tal01) was used
for SCNT.
3.3. Generation of sSURF1−/− and sSURF1+/− pigs by SCNT
As for piglets deriving from TALENs experiments, we made a ﬁrst
SCNT experiment, using 4 cell clones with small Indel including the
C2Tal01 clone and obtained a 5-piglet litter, four of which were born
alive. In order to exclude potential large oﬀspring syndrome, sometime
occurring as a consequence of SCNT [36], we re-cloned one of these
piglets (ID487, originated from C2Tal01) that showed no defects at-
tributable to SCNT procedure to generate all the piglets for the sub-
sequent experiments. In addition to genotypic validation, the sSURF1−/
Fig. 1. Schematic representation of experimental designs for the generation of SURF1−/− cells and derived pigs. A) Schematic representation of SURF1 protein and
cDNA, and of the strategy used to generate the mutant allele with the targeting vector. N-TM and C-TM, N- and C-terminal transmembrane domains, HR, homologous
recombination; P, puromycin resistance cassette; Ex, exon. Ex2Fw, Ex4Rv, and PuroF2R: oligos used to PCR amplify the genomic SURF1 alleles, giving the bands
indicated. Δ3, in yellow is the residual exon 3 after the insertion of the targeting vector.
B) NHEJ of the second allele. Sequence of a SURF1+/+ (Z11; upper sequence) and cloned SURF1−/− pigs (lower panels). The black box in the wild-type allele
indicates the 106 bp sequence eliminated by homologous recombination in the targeted allele. The red box on the left part of the wild type sequence indicates the
position of the 5-bp deletion obtained using TALENS (#487); the sequence of the mutant allele is magniﬁed below. The black arrow indicates the junction point. The
red box on the right part of the wild type sequence indicates the region where an additional A (black arrow) has been inserted by CRISPR/Cas9; the sequence of the
mutant allele is magniﬁed below (#498). These results demonstrate that cloned SURF1−/− individuals carry one allele disrupted by the insertion of Puromycin and
the other allele containing either the 5 bp deletion obtained by TALENs (ID 487) or the 1 bp insertion obtained by CRISPR/Cas9 editing. As a result, cloned SURF1−/
− pigs contain two null SURF1 alleles.
C) WB on liver mitochondrial enriched fraction from 3 SURF1+/+ and a SURF1−/− pigs, showing the absence of SURF1 protein in SURF1−/− pigs. VDAC1 and
TOM70 were used as loading controls. Pigs 539 and 542 were generated using TALENs, pig 498 CRISPR/Cas9.
Table 1
Results of transfection experiments. Percentages are calculated on the total number of colonies picked up for each experiment. KO= SURF−/−; HET=SURF+/−.
*colonies are not targeted (because the HR vector was not used in this transfection), but positive for the introduction of site-speciﬁc InDels.
Transfection mix Fibroblast cell line ID (M/F) N° colonies N° targeted colonies (%) N° sequenced colonies (%) N° colonies suitable for SCNT (%)
Tal01L+R+HR vector 6639 (M) 48 32 (67%) 14 (29%) 10 (21%) KO
Tal02L+R+HR vector 6639 (M) 42 23 (55%) 8 (19%) 3 (7%) KO
Tal01L+R+HR vector 167 (F) 38 25 (66%) 5 (13%) 5 (13%) HET
CRISPR PAM90 6639 (M) 118 16 (14%)* 79 (67%) 10 (8%) HET
CRISPR PAM90+HR vector clone-5 100 14 (14%) 40 (40%) 10 (10%) KO
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− animals derived from ID487 recloning were phenotypically validated
to lack the sSURF1 protein by Western-blot (WB) immunodetection
(Fig. 1C).
A total of 24 SCNT experiments, resulting in 11 farrowings
(TALENs- and CRISPR/Cas9-derived animals), were obtained, and a
total of 75 animals of both sexes and all genotypes were generated
(Table 2). SCNT eﬃciency ranged from 1% to 10%.
3.4. Clinical phenotype of SURF1−/− piglets
Overall, 38 sSURF1−/− male piglets were generated, 13 of which
(34%) were stillborn. Eleven out of the 25 individuals born alive died or
were culled the same day of birth due to severe clinical phenotype,
including severe tremors, absent or weak suckling and rooting reﬂexes.
Six SURF1−/− piglets lived for 6–9 days and neurological examination
revealed impaired hindlimb retraction and cranial tibial reﬂexes
starting from day 3. These reﬂexes were normal in age-matched
controls and sSURF1+/− animals. In the following days, the sSURF1−/
− piglets developed failure to thrive and showed diﬃculties in swal-
lowing with weak or absent suckling and rooting reﬂexes, inability to
recognize food, poor weight gain (Fig. 2B) often associated with diar-
rhoea, and altered perception of the surrounding space with a tendency
to hurt themselves. In two cases with farrowing of a single sSURF1−/−
piglet, the animals were removed from the sow and hand-raised in an
intensive care unit under artiﬁcial feeding conditions. Under such
conditions, the two piglets lived for more than one week (29 days and
80 days) compared to the piglets left nursing under the mother. Both
piglets (one derived from CRISPR/Cas9-edited colony and one from
TALENs-derived colony) showed facial dysmorphism (Fig. 2A), char-
acterized by shorter nose, bilateral eyelid ptosis, weakness of facial
muscles, in addition to pronounced body tremors with diﬀuse muscle
weakness, respiratory problems and markedly reduced growth (not
shown). Whilst at birth body weights of sSURF1−/− piglets were
comparable with those of control littermates, they failed to thrive and
remained signiﬁcantly smaller than cloned age-matched wild-type
controls and sSURF1+/− animals (Fig. 2B). Both longer-lived sSURF1−/
− piglets died of sepsis, favoured by dysphagia and by the general
critical state of the animals in the last days before death. The infectious
agents of which the two piglets died were detected only in these two
animals, not in any other piglet housed in the same facility, suggesting a
severe debilitation with consequent impaired immune system function.
As for the sSURF1+/− controls, 14 male and 12 female piglets were
generated following the same procedures as for sSURF1−/−, and they
appeared phenotypically normal without the clinical signs observed in the
sSURF1−/− animals. Overall, the Kaplan-Meier survival curve showed a
highly signiﬁcant reduction in the lifespan of sSURF1−/− (survival median
3 days) vs. sSURF1+/− and wild type control piglets (log-rank test
p < 0.001) at 28 days (Fig. 2C). No signiﬁcant diﬀerences resulted from
the comparison between survival rates of sSURF1+/− piglets and wild type
controls (log rank test p=0.264).
Comparison between blood lactate measurements at birth in
sSURF1−/− vs. sSURF1+/− piglets showed no diﬀerence, however
Fig. 2. Phenotypic characterization of
swine SURF1−/− model.
A) Pictures showing the facial dysmorphic
features in SURF1−/− compared to
SURF1+/− littermate piglets.
B) Daily weight gain (% of birth weight) of
SURF1−/− (day 1, n=20) vs. SURF1+/+
(day 1, n= 37) and SURF1+/− (day 1,
n= 28) piglets nursed under the mother
during the ﬁrst 9 days of life (animals arti-
ﬁcially fed were excluded from this ana-
lysis). Data are presented as mean percen-
tage of daily weight gain/birth
weight ± SEM. The data were analysed
using one-way ANOVA. The asterisks refer
to the signiﬁcance between SURF1−/− and
SURF1+/+ (CTR). *p< 0.05; **p< 0.01;
***p< 0.005. No statistical analysis was
carried out for ages 7–9 because only one
SURF1−/− animal per time point survived.
C) Kaplan-Meier survival curves for the
various genotypes.
D) Blood lactate concentration in SURF1−/
− (KO; n=12) vs. SURF1+/+ (CTR; n= 8)
piglets at P1.
Table 2
Summary of cloned SURF1 piglets obtained throughout the SCNT experiments.
All animals born were PCR-genotyped and the SURF1+/− (HET) or SURF1−/−
(KO) condition was conﬁrmed by Sanger sequencing. Taking into account the
necessary genetic equivalence of piglets deriving from re-cloning experiments
of ID487, only a representative random sample of piglets/litter were conﬁrmed
by Sanger sequencing.
Somatic cell
nuclear donor
line ID
M/F KO or HET
(nuclease+ vector)
Oﬀspring
(% alive)
Genotype
conﬁrmed by
Sanger
sequencing
6639 (pig 487
delivery)
M KO(TALENs + HR) 5 (80%) 4
487 M KO (re-cloning) 32 (63%) 15
6639 M KO (CRISPRs+HR) 1 (100%) 1
6639 M HET
(CRISPRs−NHEJ)
19 (74%) 19
167 F HET (TALENs+HR) 18 (77%) 17
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strong individual variability was observed among both knockout
(n=12) and control (n= 8) groups (Fig. 2D). In addition, no sig-
niﬁcant diﬀerence was detected between blood lactate level of longer-
lived sSURF1−/− ID498 and age-matched controls (not shown). Stan-
dard blood analysis, including TSH, FT3 and FT4, showed no signiﬁcant
diﬀerences between sSURF1−/− animals and controls (not shown).
3.5. Biochemical and molecular analysis of sSURF1−/− tissues
Spectrophotometric analysis of the MRC activities was performed in
tissue homogenates from quadriceps, liver and brain of one-day old
sSURF1−/− animals and age-matched wild-type (WT) controls
(Fig. 3A). In addition, we analysed the two longer-lived animals (ID498
and ID525, 80 and 29 days of age, respectively) compared to age-
matched controls (not shown). We detected a highly signiﬁcant de-
crease of the CS speciﬁc activity measured in skeletal muscle homo-
genates of sSURF1−/− animals compared to controls, as low as ap-
proximately 60% of the control mean (p < 0.0001). Thus, whilst the
values of MRC activities normalized to CS did not signiﬁcantly diﬀer
between sSURF1−/− and control muscle homogenates, the speciﬁc
activities were signiﬁcantly reduced for complex I (p= 0.0019), com-
plex II (p= 0.0018) and complex IV (p=0.0038) (Fig. 3A). Surpris-
ingly, no defects were detected in both liver (Fig. 3B) and brain
(Fig. 3C). Western blot immunovisualization conﬁrmed a slight reduc-
tion of respiratory chain subunits in skeletal muscle (Fig. 3D). 2D-BNGE
showed a reduction in CIV-containing supercomplexes (I-III2-IV and
III2-IV) but no accumulation of assembly intermediates in SURF1−/−
vs. wild type age-matched control mitochondria isolated from skeletal
muscle (Fig. 3E). Since SURF1 is a ubiquitous protein and hSURF1
mutant patients and Surf1−/− mice show COX deﬁciency in all tissues
and cell types, we analysed COX activity in primary ﬁbroblasts derived
from sSURF1−/− and age matched wild type piglets. Cultured
ﬁbroblasts derived from 3 control and 4 sSURF1−/− animals were
analysed at early passages and under age-related stress conditions, i.e.
after 15 passages in culture (Supplementary Fig. 4A), but no signiﬁcant
diﬀerence was detected with the corresponding controls in either con-
dition. These results were conﬁrmed by histochemical staining for COX
(Supplementary Fig. 4B). In addition, no obvious diﬀerences were de-
tected in the mitochondrial network (Supplementary Fig. 4B).
Histochemical COX staining in skeletal muscle conﬁrmed a mild
reduction in COX reaction in sSURF1−/− samples compared to controls
(n= 8 controls vs. 9 knockout). However 2/9 samples showed no re-
duced COX staining. No clear diﬀerences were detected in the succinate
dehydrogenase (SDH) staining in sSURF1−/− vs. sSURF1+/+ (Fig. 4A),
although 2/9 sSURF1−/− muscles showed that SDH staining was
slightly increased compared to the controls. The absence of SDH deﬁ-
ciency may be due to the poor sensitivity of SDH staining, which cannot
detect the mild reductions we measured in the spectrophotometric as-
says. Finally, the same analysis on jejunum samples revealed the pre-
sence of villi with pronounced COX deﬁciency (Fig. 4B). This result
could be related to the observed reduced growth of the sSURF1−/−
piglets.
The puzzling discrepancy between the severity of the phenotype of
sSURF1−/− piglets and the lack of speciﬁc COX deﬁciency typical of
hSURF1 mutated patients and Surf1−/− mice, prompted us to perform
an unbiased total mRNA sequencing experiment on skeletal muscle of
sSURF1−/− and WT animals (n= 2/group). A ﬁrst result was that
sSURF1 mRNAs in genotypically proven sSURF1−/− animals were in-
deed carrying the expected mutations (Supplementary Fig. 5).
Diﬀerential expression of genes was evaluated using DESeq2. About 70
genes were over-expressed and 142 were under-expressed (adjusted p-
value< 0.05) in sSURF1−/− vs. WT animals (Supplementary Table S4).
Interestingly, several genes encoding subunits of the mitochondrial
respiratory chain were present among the under-expressed genes.
Fig. 3. Biochemical characterization of swine SURF1−/− tissues.
A–C) MRC speciﬁc activities (nmoles/min/mg of proteins) in quadriceps (A) liver (B), and brain (C) of newborn SURF1−/− piglets. Two-tailed, unpaired, unequal
variance Student's t-test was used for statistical analysis (***p < 0.005).
D) Western blot analysis of subunits of the respiratory chain.
E) 2-D BNGE Western-blot of muscle mitochondria from a newborn SURF1−/− piglet and an age-matched control. Immunovisualization was obtained by using an
anti-COI speciﬁc antibody. I-III-IV and III-IV are COX-containing supercomplexes. M indicates the COX monomer and AI a commonly detected assembly intermediate.
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DAVID functional analysis of these genes indicated that Gene Ontology
(GO) terms that were signiﬁcantly (Benjamini p-value<0.05) over-
represented included “cytochrome c oxidase activity”, “mitochondrial
respiratory chain”, “mitochondrial respiratory chain complex I”, and
“mitochondrial respiratory chain complex IV” (not shown), suggesting a
role of SURF1 in assembly/stability of supercomplexes, in keeping with
the 2D-BNGE experiments. In contrast, for the over-expressed genes
there were no GO clusters that were signiﬁcantly over-represented.
By broadening the functional analysis of the under-expressed genes,
including the genes with a fold-change diﬀerence of> 20% compared
to the wild-type (about 3000 genes), GO terms signiﬁcantly over-re-
presented included “translation”, “mitochondrion”, “oxidative phos-
phorylation” and “cytosolic large ribosomal subunit” (Supplementary
Table S5). To investigate further the diﬀerences in expression of the
diﬀerent functional categories of genes, we highlighted various gene
sets deﬁned in terms of structural complexes or GO classiﬁcation on
volcano plots of all the diﬀerentially expressed genes (Fig. 5). Some
gene sets showed a biased distribution towards being under-expressed,
including known mitochondrial genes, genes belonging to complex IV,
the cytosolic ribosome, the mitochondrial ribosome, or annotated in the
Gene Ontology as involved in fatty acid metabolism or the proteasome.
3.6. Neuropathological ﬁndings
To investigate the presence of abnormalities in the nervous system,
we examined four sSURF1−/− piglets culled at perinatal stage and the
two longer-lived sSURF1−/− piglets (29 d and 80 d of age) and age
matched controls. No overt neurodegeneration was detected in H&E
stained sections through the entire extension of the central nervous
system (CNS); only some cleaved caspase 3 positive neurons were de-
tected in hypoglossal nerve nuclei in the brainstem of the 29 day-old
sSURF1−/− piglet (data not shown).
The most consistent ﬁnding in sSURF1−/− piglets was a signiﬁcant
reduction in the cortical thickness of the cerebrum at early postnatal
ages as compared with wild type swine (sSURF1−/− perinatal:
738 ± 16 μm vs. sSURF+/−: 1057 ± 23 μm; unpaired t-test
p≤ 0.0001; sSURF1−/− 1 day old: 921 ± 31 μm vs. sSURF+/−
1150 ± 31 μm, unpaired t-test p≤ 0.0001); however, this decrease
was not statistically signiﬁcant in the 29 day old sSURF1−/− piglet
(sSURF1−/−: 1108 ± 43 μm vs. sSURF+/− 1186 ± 41 μm, unpaired t-
test p= n.s.; Fig. 6A). Moreover, cortical layering diﬀerences were
observed in perinatal sSURF1−/− piglets as compared to controls. In
particular, sSURF1−/− animals showed a higher cellular density and a
disorganized cortical structure with several immature neurons, as also
revealed by DCX immunostaining (Fig. 6B). No signs of vascular pro-
liferation were detected at all ages analysed by means of Isolectin B4
immunostaining (Fig. 6C). Architecture of basal ganglia, hippocampus,
thalamic region and cerebellum were similar to age matched control.
GFAP staining revealed a diﬀerent glial cell distribution pattern be-
tween sSURF1−/− and sSURF1+/− piglets at all ages analysed. In
sSURF1+/− animals, GFAP was expressed mainly in the white matter
(WM) areas whereas sSURF1−/− brains showed numerous GFAP posi-
tive astrocytes in the grey matter (GM) of cerebral and cerebellar
cortex, especially around the vessels. Quantiﬁcation of the signal in the
cerebellum conﬁrmed this trend in the longer-lived sSURF1−/−
(Fig. 6D). Iba1 staining pattern was similar in sSURF1−/− and WT
piglets and revealed a more uniform distribution of microglia between
white and grey matter areas at perinatal and 29 days of age. Quantiﬁ-
cation of Iba1 signal in the cerebellum revealed an increase in the
80 days longer-lived sSURF1−/− piglet (Fig. 6E). The same piglet
showed diﬀuse microgliosis, more prominent in the cerebral cortex grey
matter with activated microglial cells showing hypertrophic rounded
soma with thickened, shorter and fewer ramiﬁed processes as con-
ﬁrmed by quantiﬁcation (Fig. 6E, lower panel). The analysis of Luxol
Fast Blue histological staining and MBP immunohistochemical staining
in cortex, basal ganglia, mesencephalon and cerebellum of the older
sSURF1−/− piglet revealed normal myelinating process (Fig. 6F).
4. Discussion
Mouse models are valuable tools to unravel the molecular and
biochemical mechanisms underpinning mitochondrial diseases, but
they often fail to develop the qualitative and/or quantitative clinical
features of the human pathology. Surf1−/− mice are a striking example
of this, as they display partial COX deﬁciency, but hardly any patho-
logical phenotype. Conversely, in LS patients, SURF1 ablation causes a
devastating, early-onset, invariably fatal encephalopathy associated
with a typical isolated COX deﬁciency. We thus decided to produce the
ﬁrst sSURF1−/− pig model. To this aim, we managed to sequence the
whole sSURF1 gene and annotated all the 9 exons (only exons 3–5 were
previously annotated on public databases). We disrupted the sSURF1
gene using two alternative methods, TALENs and CRISPRs, in primary
porcine ﬁbroblast cell lines, and used them for high eﬃciency SCNT.
The pathological phenotypes observed in the two knock-out models of
Fig. 4. Histochemical ﬁndings in swine SURF1−/− model.
A) COX (a, b) and SDH (c, d) staining of quadriceps from newborn SURF1+/+ and SURF1−/− piglets. Note the paler colour in both stainings in SURF1−/− samples,
suggesting a general reduction of MRC activities.
B) COX staining of jejunum villi from newborn SURF1+/+ and SURF1−/− piglets. Note the reduction in COX staining in the SURF1−/− sample.
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sSURF1−/− piglets were remarkably similar, independently of the nu-
clease used and the speciﬁc gene disruption obtained by the two ap-
proaches, indicating that it was only related to the absence of sSURF1
and ruling out the possibility that it could be due to oﬀ-target eﬀects.
Notably, sSURF1+/− piglets (both males and females) that were gen-
erated using the same reagents and procedures as sSURF1−/− litter-
mates did not show any pathological sign and did not diﬀer sig-
niﬁcantly from sSURF1+/+ controls. Moreover, the older sSURF1+/−
sow was demonstrated to be fertile as a pregnancy was successfully
established using a WT boar.
The clinical phenotype associated with the ablation of sSURF1 was
extremely severe and characterized by growth retardation/arrest,
failure to thrive and persistent tremors, supporting a fundamental role
of SURF1 in post-natal survival of the pig. The survival of the piglets
could only be prolonged a few weeks by rising them in intensive care
and with artiﬁcial feeding. Surprisingly, however, a multiple defect of
the speciﬁc activities of complexes I, II and IV was detected in
sSURF1−/− skeletal muscle, associated with marked decrease of CS
activity, whereas no MRC defect was measured in cultured ﬁbroblasts.
A puzzling feature of the sSURF1−/− pigs was the variability observed
in COX and SDH histochemical reactions. Nevertheless, the biochemical
quantiﬁcation of COX and CII speciﬁc activities showed a signiﬁcant
decrease in sSURF1−/− muscle samples compared to controls, whereas
no signiﬁcant diﬀerences were detected in other tissues (e.g. liver,
brain, and cultured ﬁbroblasts). This is also an unexplained discrepancy
of the sSURF1−/− model, compared to other mammalian organisms,
Fig. 5. The main pathways aﬀected by
SURF1 ablation in pigs.
Each volcano plot shows for a gene the fold-
change in its expression versus the statis-
tical signiﬁcance (p-value) of its fold-
change between SURF1 ablated pigs (n= 2)
and WT pigs (n= 2) (calculated by using
DESeq2). Each panel highlights genes of
diﬀerent Gene Ontology terms: mitochon-
drion (red); complex IV (blue); mitochon-
drial ribosome (green); cytosolic ribosome
(purple); fatty acid metabolism (orange);
and proteasome (yellow). Gene sets en-
coding subunits of the respiratory com-
plexes (only complex IV shown for clarity)
or classiﬁed according to the Gene Ontology
terms “mitochondrial and cytosolic ribo-
some”, “fatty acid metabolism” and “pro-
teasome” showed a biased distribution to-
wards being under-expressed (calculated by
using the non-parametric Mann-Whitney-
Wilcoxon two-sample test).
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including mouse and human, which are characterized by generalized
COX deﬁciency, detected in all tissues and cell types examined.
A role for SURF1 in COX assembly and/or stability has been de-
monstrated in several organisms where the absence of SURF1 leads to
COX deﬁciency and accumulation of COX assembly intermediates [37].
In yeast, a role for the SURF1 ortholog, SHY1, in the hemilation of
COX1 has been proposed, whereas in humans SURF1 has been sug-
gested to be involved in the incorporation of COX2 in nascent complex
IV [38]. In other species, notably in Drosophila melanogaster, con-
stitutive knockdown of d.SURF1 is associated with poor somatic growth
of larvae, and developmental arrest leading to death at the pre-pupal
stage, with modest but signiﬁcant defects of all the MRC activities [39].
This resembles the condition observed in our sSURF1−/− animals. In-
terestingly, when the dSURF1 knockdown is restricted to the cephalic
segment of the adult ﬂy, then a clear cut, isolated COX defect is de-
tected [39]. The exact role of SURF1 in COX assembly in mammals
remains, however, unclear. Taken together, these observations suggest
that SURF1 may play a role in the stabilization/activity of the MRC
complexes, possibly in a species and developmental speciﬁc manner.
Accordingly, it has been recently shown that COX accumulates less in
SC in mouse than in humans and that COX is more stable in Surf1−/−
mice than in LSSURF1 patients [37]. In case of sSURF1, its complete
constitutive ablation severely impairs the somatic development and
overall survival of the neonatal or suckling piglets, associated with
reduced activity of COX as well as other mitochondrial enzymes, in-
cluding MRC complexes and CS, in skeletal muscle. Indeed, our RNAseq
analysis showed that the expression of several transcripts associated
with the respiratory chain were down regulated in sSURF1−/− vs.
sSURF1+/+ animals. In addition, other pathways, including translation
and proteome related-genes were signiﬁcantly aﬀected, suggesting
sSURF1 ablation interferes with several pathways, although their con-
tribution to the phenotype is currently unknown.
The most striking clinical phenotype observed in our sSURF1−/−
piglets is reduced/arrest of somatic growth, which is not surprising if
one considers that weight gain, mainly due to massive expansion in
muscle and fat tissues, is possibly the most prominent feature of farmed
Fig. 6. Histological analysis of brain.
A) H&E of SURF1+/+ and SURF1−/− piglets showing unidentiﬁable layer formation, high cellular density and a signiﬁcant reduction of cerebral cortex grey matter
thickness in newborn SURF1−/− piglets. Quantiﬁcation of these parameters are shown in the graph. Data are means ± SEM, unpaired t-test, ****p < 0,0001. Scale
bar, 100 μm.
B) Doublecortin (DCX) staining of some immature neurons in the superﬁcial region of cerebral cortex in newborn SURF1−/− piglets as compared to age-matched
SURF1+/+ animals. Scale bar, 25 μm. C) Vascular proliferation assessment by isolectin B4 staining of endothelial cells. No diﬀerences in vasculature in SURF1+/+
and SURF1−/− brains were detected at all ages analysed. Scale bar, 100 μm D–E) Analysis of the brain of the longer-lived piglets. D) Increased Iba1 staining in
SURF1+/+and SURF1−/− piglets' cerebral cortex indicating gliosis with prominent microgliosis. Graphs showing quantiﬁcation of the two signals (% of the total
area) in grey and white matter areas. Data are means ± SD scale bar, 50 μm. E) Iba1 staining of cerebellum from SURF1+/+ and SURF1−/− animals. Graph shows
the number of Iba1 positive cells. Control animal shows resting microglia with a small soma and ramiﬁed morphology. In the SURF1−/− litter, activated microglia
appears swollen with shorter, less ramiﬁed and thicker processes. Graph showing microglia mean size. Data are presented as means ± SD. Scale bar, 20 μm. F) MBP
staining in SURF1+/+ and SURF1−/− cerebellar cortex showing comparable myelinated process at 80 days of age. Scale bar, 50 μm.
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pre-pubertal swine. In contrast with what is observed in humans, the
absence of sSURF1 in pigs resulted in modest neuropathological
changes at early postnatal ages, consisting of diﬀerences in cortical
architecture associated with the presence of immature still migrating
DCX positive neurons and numerous astroglial cells. A consistent fea-
ture was the presence of microgliosis especially within the cerebral
cortex in the longer-surviving sSURF1−/− animal, a feature that is also
reported in LS associated pathology. Although an inter-individual het-
erogeneity should be considered, a delayed or altered cortical devel-
opment of sSURF1−/− swine could not be excluded but these features
are modest compared to the dramatic somatic growth arrest, and cer-
tainly marginal in comparison to the cerebral lesions hallmarking the
human condition. It has to be noted that in the clinical cases of LS (as in
any clinical situation) the complete genetic background is not known,
thus the presence of compensatory mechanisms or mutation(s) in other
genes can change the course of the syndrome. For example, a recent
paper identiﬁed healthy individuals resilient to highly penetrant forms
of genetic childhood disorders [40]. Therefore, the information coming
from the study of each animal model of the same pathology (e.g. LS)
does not or cannot necessarily replicate exactly the human condition,
but can be useful to investigate diﬀerent metabolic and/or physiologic
pathways involved in the onset of the pathology of interest. In addition,
in humans the brain/body mass ratio is clearly diﬀerent from that of
other animals and this could explain why in humans the cerebral lesions
prevail, whereas in the pig the prevailing tissues aﬀected are the in-
testine and skeletal muscles, whose failure brings the animals to death
with no major cerebral lesions. In conclusion, we describe a dramatic
clinical phenotype in pigs associated with the ablation of sSURF1,
which is not accompanied by the severe biochemical and structural
defect of COX typical of human LSSURF1. The mechanistic aspects of
SURF1 in COX biogenesis and, possibly, other mitochondrial pathways
are still poorly understood. The creation of constitutive, devel-
opmentally regulated models of SURF1 ablation in diﬀerent species
could help elucidate the physiological role(s) of this elusive protein in
mitochondrial and cell metabolism, and clarify the complex patho-
genesis of the SURF1-associated human disease.
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